3SBio Inc. (1530.HK)

HKD 12.8

(2.24%)

Revenue Summary of 3SBio Inc.

  • 3SBio Inc.'s latest annual revenue in 2023 was 7.81 Billion CNY , up 13.94% from previous year.
  • 3SBio Inc.'s latest quarterly revenue in 2024 Q1 was 2.19 Billion CNY , up 8.86% from previous quarter.
  • 3SBio Inc. reported a annual revenue of 6.85 Billion CNY in annual revenue 2022, up 7.48% from previous year.
  • 3SBio Inc. reported a annual revenue of 6.38 Billion CNY in annual revenue 2021, up 14.22% from previous year.
  • 3SBio Inc. reported a quarterly revenue of 2.19 Billion CNY for 2024 Q1, up 8.86% from previous quarter.
  • 3SBio Inc. reported a quarterly revenue of 2.01 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of 3SBio Inc. (2023 - 2003)

Historical Annual Revenue of 3SBio Inc. (2023 - 2003)

Year Revenue Revenue Growth
2023 7.81 Billion CNY 13.94%
2022 6.85 Billion CNY 7.48%
2021 6.38 Billion CNY 14.22%
2020 5.58 Billion CNY 5.07%
2019 5.31 Billion CNY 16.02%
2018 4.58 Billion CNY 22.75%
2017 3.73 Billion CNY 33.5%
2016 2.79 Billion CNY 67.19%
2015 1.67 Billion CNY 47.95%
2014 1.13 Billion CNY 29.18%
2013 875.39 Million CNY 33.42%
2012 656.14 Million CNY 0.0%
2011 - CNY 0.0%
2010 - CNY 0.0%
2009 - CNY 0.0%
2008 - CNY 0.0%
2007 - CNY 0.0%
2006 - CNY 0.0%
2005 - CNY 0.0%
2004 - CNY 0.0%
2003 - CNY 0.0%

Peer Revenue Comparison of 3SBio Inc.

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD -1512.471%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD -46.841%